AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Moderna share price12/28/2023 ![]() One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. But have you ever wondered about what other factors affect a stock's price? Stock prices are primarily based on seller supply and buyer demand. What Caused Moderna Inc Stock’s Price to Rise? ![]() Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions Year to date, Moderna Inc’s stock is down 56.26%. Over the last year, Moderna Inc has hit prices as high as $217.25 and as low as $95.02. Moderna Inc’s ( MRNA) price is currently down 5.59% so far this month.ĭuring the month of August, Moderna Inc’s stock price has reached a high of $117.05 and a low of $95.02. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. Moderna Inc’s price-earnings (P/E) ratio is currently at 37.6, which is high compared to the Biotechnology & Medical Research industry median of 15.4. Currently, there are 381.00 million shares of Moderna Inc stock available for purchase. Moderna Inc is up 9.31% from its previous closing price of $101.62.ĭuring the last market session, Moderna Inc’s stock traded between $101.40 and $107.26. Moderna Inc’s Stock Price as of Market CloseĪs of August 21, 2023, 4:00 PM CST, Moderna Inc’s stock price was $111.08. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips. Want to learn more about Moderna Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Moderna Inc. It has a development pipeline of 45 development candidates across its 48 development programs, of which 38 are in clinical studies. ![]() The Company's products include Spikevax, the Moderna COVID-19 vaccine (mRNA-1273), a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax (mRNA-1273.214), and bivalent vaccine targeting the BA.4/BA.5 Omicron variants combined with Spikevax (mRNA-1273.222). ![]() mRNA medicines are designed to direct the body?s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company is focused on developing messenger ribonucleic acid (mRNA) therapeutics and vaccines. Stock price momentum as measured by its relative strengthīefore we jump into Moderna Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.In this article, we go over a few key elements for understanding Moderna Inc’s stock price such as: A smart way to take the guesswork out of knowing when to buy or sell Moderna Inc’s stock is to have the right tools and resources as well as a clear monitoring process. One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.īut what if you had the insights to effectively evaluate a company like Moderna Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes.
0 Comments
Read More
Leave a Reply. |